Clinical Trial Update: CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO [Phase 2]

View source ↗

Summary

Phase 2 trial comparing a CDK4/6 inhibitor with endocrine therapy to chemotherapy with endocrine therapy in advanced/metastatic breast cancer; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-negative Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• CDK4/6 inhibitor
• Chemotherapy (chemotherapy)
• Endocrine therapy

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Hormone Receptor Positive Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: COMPLETED